The 20 Best Dysferlinopathy Doctors Near Me in New York, NY
Find the Top Dysferlinopathy Experts and Specialists
The 20 Best Dysferlinopathy Doctors near New York, NY
MediFind found 39 doctor with experience in Dysferlinopathy near New York, NY. Of these, 36 are Experienced and 3 are Advanced.
Office
Cristina Drafta is a Neurologist in New York, New York. Dr. Drafta is rated as an Experienced provider by MediFind in the treatment of Dysferlinopathy. Her top areas of expertise are Foot Drop, Neuralgia, Peripheral Neuropathy, and Movement Disorders.
Office
Kiril Kiprovski is a Neurologist in New York, New York. Dr. Kiprovski is rated as an Experienced provider by MediFind in the treatment of Dysferlinopathy. His top areas of expertise are Congenital Insensitivity to Pain with Anhidrosis, Infantile Axonal Neuropathy, Hereditary Sensory and Autonomic Neuropathy Type 2, and Hereditary Neuralgic Amyotrophy.
Gramercy Park Physicians LLP
Daniel Macgowan is a Neurologist in New York, New York. Dr. Macgowan is rated as an Experienced provider by MediFind in the treatment of Dysferlinopathy. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Spinal and Bulbar Muscular Atrophy, and Spinal Muscular Atrophy Type 3.
Saint Lukes Roosevelt Hospital Lab
Shanna Patterson is a Neurologist in New York, New York. Dr. Patterson is rated as an Experienced provider by MediFind in the treatment of Dysferlinopathy. Her top areas of expertise are GM1 Gangliosidosis, Peripheral Neuropathy, Cramp-Fasciculation Syndrome, and Gangliosidosis.
Nyu
Jeffrey Cohen is a Physiatrist in New York, New York. Dr. Cohen is rated as an Advanced provider by MediFind in the treatment of Dysferlinopathy. His top areas of expertise are Poliomyelitis, Foot Drop, Relapsing Multiple Sclerosis (RMS), and Glycogen Storage Disease Type 13.
SUNY Downstate Medical Center
Yaacov Anziska is a Neurologist in Brooklyn, New York. Dr. Anziska is rated as an Advanced provider by MediFind in the treatment of Dysferlinopathy. His top areas of expertise are Myasthenia Gravis, Neuromyelitis Optica, Necrotizing Myopathy (NM), and HTLV-1 Associated Myelopathy.
Xie Yi Medical Office PC
Yi Xie is a Pediatric Neurologist in New York, New York. Dr. Xie is rated as an Experienced provider by MediFind in the treatment of Dysferlinopathy. His top areas of expertise are Athetosis, Infantile Axonal Neuropathy, Congenital Insensitivity to Pain with Anhidrosis, Hereditary Sensory and Autonomic Neuropathy Type 2, and Deep Brain Stimulation.
Gramercy Park Physicians LLP
Stephen Scelsa is a Neurologist in New York, New York. Dr. Scelsa is rated as an Experienced provider by MediFind in the treatment of Dysferlinopathy. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Spinal Muscular Atrophy Type 3, and Spinal and Bulbar Muscular Atrophy.
NYU Langone Orthopedic Hospital
Mary Chu is a Neuromusculoskeletal Medicine provider in New York, New York. Dr. Chu is rated as an Experienced provider by MediFind in the treatment of Dysferlinopathy. Her top areas of expertise are X-Linked Infantile Spinal Muscular Atrophy, Spinal Muscular Atrophy Type 2, Spinal Muscular Atrophy with Arthrogryposis, and Limb-Girdle Muscular Dystrophy.
NYU Langone Orthopedic Hospital
Renat Sukhov is a Pediatrics provider in New York, New York. Dr. Sukhov is rated as an Experienced provider by MediFind in the treatment of Dysferlinopathy. His top areas of expertise are Cerebral Palsy, Spastic Diplegia Infantile Type, Hemiplegia, and Alternating Hemiplegia of Childhood.
Hairline Illusions LLC
Gil Roter is a primary care provider, practicing in Internal Medicine in New York, New York. Dr. Roter is rated as an Experienced provider by MediFind in the treatment of Dysferlinopathy. His top areas of expertise are Dementia, Hemiplegia, Hypertensive Heart Disease, and Peptic Ulcer.
Oda Primary Health Care Network Inc.
Walter Molofsky is a Neurologist in Brooklyn, New York. Dr. Molofsky is rated as an Experienced provider by MediFind in the treatment of Dysferlinopathy. His top areas of expertise are Vein of Galen Aneurysm, GAPO Syndrome, Autism Spectrum Disorder, and Tension Headache.
Office
Amanda Murphy is a Pediatric Neurologist in New York, New York. Dr. Murphy is rated as an Experienced provider by MediFind in the treatment of Dysferlinopathy. Her top areas of expertise are Duchenne Muscular Dystrophy and Dysferlinopathy.
Rockefeller Outpatient Pavilion
Lisa Deangelis is an Oncologist in New York, New York. Dr. Deangelis is rated as an Experienced provider by MediFind in the treatment of Dysferlinopathy. Her top areas of expertise are Primary Lymphoma of the Brain, Posterior Fossa Tumor, Gliosarcoma, and Embryonal Tumor with Multilayered Rosettes. Dr. Deangelis is currently accepting new patients.
Hospital For Special Surgery
David Hyams is a Physiatrist in New York, New York. Dr. Hyams is rated as an Experienced provider by MediFind in the treatment of Dysferlinopathy. His top areas of expertise are Cerebral Palsy, Invertebral Disc Disease, Post Polio Syndrome, and Bursitis.
HSS 75TH Street Campus
Joseph Feinberg is a Physiatrist in New York, New York. Dr. Feinberg is rated as an Experienced provider by MediFind in the treatment of Dysferlinopathy. His top areas of expertise are Hereditary Neuralgic Amyotrophy, Brachial Plexopathy, Axillary Nerve Dysfunction, and Thoracic Outlet Syndrome. Dr. Feinberg is currently accepting new patients.
Mount Sinai
Susan Shin is a Neurologist in New York, New York. Dr. Shin is rated as an Experienced provider by MediFind in the treatment of Dysferlinopathy. Her top areas of expertise are Primary Lateral Sclerosis, Guillain-Barre Syndrome, Infantile Axonal Neuropathy, and Hereditary Sensory and Autonomic Neuropathy Type 2.
Marina Neystat is a Neurologist and an Internal Medicine provider in Forest Hills, New York. Dr. Neystat is rated as an Experienced provider by MediFind in the treatment of Dysferlinopathy. Her top areas of expertise are Benign Paroxysmal Positional Vertigo, New Daily Persistent Headache (NDPH), Migraine, and Chronic Demyelinizing Neuropathy with IgM Monoclonal.
CUIMC/Neurological Institute Of New York
Matthew Harms, MD is an Associate Professor of Neurology. Dr. Harms received his A.B. in Biology summa cum laude from Harvard University in 1997, and his medical doctorate from the University of California San Francisco in 2003. He remained at San Francisco for neurology residency and served as Chief Resident in his final year. Dr. Harms completed neuromuscular medicine and clinical neurophysiology fellowships under the mentorship of Dr. Alan Pestronk at Washington University in St. Louis. His clinical training in neuromuscular diseases led him into the laboratory of Dr. Robert Baloh, where his post-doctoral research identified the genes responsible for two orphan human diseases- dominant spinal muscular atrophy with lower extremity predominance and limb-girdle muscular dystrophy type 1D.Dr. Harms joined the neuromuscular medicine faculty at Washington University in 2009 with board certifications in neurology, clinical neurophysiology, and neuromuscular medicine. In 2011, Dr. Harms assumed leadership of the Washington University Neuromuscular Genetics Project and established his research laboratory to continue harnessing emerging genetic technologies to understand the causes of inherited neuromuscular diseases. The lab focuses on diseases of the motor neuron, including amyotrophic lateral sclerosis, spinal muscular atrophy, and the hereditary motor neuropathies, and where his efforts have helped identify more than 5 novel disease genes. Here at Columbia, he will continue these efforts, directing an international multi-site effort using whole genome and transcriptome sequencing to bring precision medicine to amyotrophic lateral sclerosis. His laboratory efforts will occur in both the Motor Neuron Center and the Institute for Genomic Medicine. Dr. Harms is rated as an Advanced provider by MediFind in the treatment of Dysferlinopathy. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Spinal Muscular Atrophy (SMA), and Spinal Muscular Atrophy Type 3.
CUIMC/Harkness Pavilion
Dr. Chiriboga is Professor of Neurology and Pediatrics at CUIMC and former Interim Director of the Division of Child Neurology, Departments of Neurology and Pediatrics, Vagelos College of Physicians and Surgeons. She is also former Chief of Pediatric Neurology at Columbia University's affiliate hospital, Harlem Hospital Center.Dr. Chiriboga was born in Peru and educated in Argentina, where she graduated with Honors from the Faculty of Medicine at the National University of Buenos Aires in 1982. Dr. Chiriboga completed training in pediatrics at St. Luke's-Roosevelt Hospital in 1985. After completing her training in child neurology in 1988 at the Neurological Institute and Babies Hospital of Columbia-Presbyterian Medical Center, Dr. Chiriboga joined the Division of Child Neurology at NewYork-Presbyterian/Columbia University Irving Medical Center. Subsequently, she completed a Neuroepidemiology fellowship at the Gertrude H. Sergievsky Center and received a Master in Public Health from the Mailman School of Public Health, Columbia University. Dr. Chiriboga serves/has served on committees of the NIH, CNS, and ABPN. She is a diplomate of the ABPN in Child Neurology.Dr. Chiriboga's current research focuses on Spinal Muscular Atrophy (SMA) clinical trials. Past areas of research, including NIH funding, has focused on congenital infections and neurodevelopmental disorders, including cerebral palsy and effects of perinatal exposures. Her clinical practice focuses on neuromuscular disorders as well as developmental, neurobehavioral neurology, and migraine, and on the treatment of spasticity. Dr. Chiriboga is rated as an Experienced provider by MediFind in the treatment of Dysferlinopathy. Her top areas of expertise are Spinal Muscular Atrophy (SMA), Primary Lateral Sclerosis, Spinal Muscular Atrophy Type 2, and Spinal Muscular Atrophy Type 3.
Last Updated: 02/22/2026

